Biocept (BIOC)

Add to Watchlists
Create an Alert
5.03 +0.05  +1.00% NASDAQ Apr 22, 8:00PM BATS Real time Currency in USD
View Full Chart
BIOC Price Chart
View All Performance Charts

BIOC Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Biocept is up N/A over the last year vs S&P 500 Total Return up 22.85%, Icon up 48.71%, and Alliance HealthCare up 212.1%.

Get Quote for

Portfolio Strategies Featuring BIOC

Did Biocept make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

BIOC Profile

  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Medical Laboratories
  • NAICS Code: 621511
  • NAICS Industry: Medical and Diagnostic Laboratories
  • NAICS Industry Code: 6215
  • NAICS Sector: Health Care and Social Assistance
  • NAICS Sector Code: 62

Biocept Inc is a cancer diagnostics company. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample.

Recent Quotes

Symbol Price Chg Chg % Market Cap
BIOC 5.03 +0.05 +1.00% 22.38M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.